-transparent.png){kind=logo}
Eleven patients with acute lymphocytic leukemia in relapse were treated with L-asparaginase and cytosine arabinoside (1-beta-D-arabinofuranosylcytosine) in induction therapy and the same drugs plus cyclophosphamide in maintenance therapy. Three patients had complete remissions lasting 6, 16, and 78+ weeks. One patient experienced partial remission and four had decreased bone marrow or peripheral blasts but were not clinically improved. The responses, which were brief, lasted 1-16 weeks with one exception of 78+ weeks. Four patients had allergic reactions to L-asparaginase that were unpredictable with assays of antibodies against L-asparaginase.
Related Publications
W A Smithson, and
G S Gilchrist, and
E O Burgert
January 1978,
Medical and pediatric oncology,
W A Smithson, and
G S Gilchrist, and
E O Burgert
September 1978,
Cancer treatment reports,
W A Smithson, and
G S Gilchrist, and
E O Burgert
January 1984,
Sangre,
W A Smithson, and
G S Gilchrist, and
E O Burgert
January 1977,
Medical and pediatric oncology,
W A Smithson, and
G S Gilchrist, and
E O Burgert
September 1987,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
W A Smithson, and
G S Gilchrist, and
E O Burgert
March 1976,
Cancer,
W A Smithson, and
G S Gilchrist, and
E O Burgert
January 1979,
Medical and pediatric oncology,
W A Smithson, and
G S Gilchrist, and
E O Burgert
February 1977,
Cancer research,
W A Smithson, and
G S Gilchrist, and
E O Burgert
February 1985,
Gan to kagaku ryoho. Cancer & chemotherapy,
W A Smithson, and
G S Gilchrist, and
E O Burgert
January 1991,
Haematologica,
